We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,623 hedge funds and large institutions have $295B invested in Johnson & Johnson in 2022 Q3 according to their latest regulatory filings, with 115 funds opening new positions, 1,691 increasing their positions, 1,445 reducing their positions, and 117 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more call options, than puts

Call options by funds: $3.67B | Put options by funds: $2.74B

17% more repeat investments, than reductions

Existing positions increased: 1,691 | Existing positions reduced: 1,445

0.2% less ownership

Funds ownership: 69.11%68.92% (-0.2%)

2% less first-time investments, than exits

New positions opened: 115 | Existing positions closed: 117

1% less funds holding

Funds holding: 3,6723,623 (-49)

6% less funds holding in top 10

Funds holding in top 10: 773730 (-43)

8% less capital invested

Capital invested by funds: $321B → $295B (-$26.2B)

Holders
3,623
Holders Change
-49
Holders Change %
-1.33%
% of All Funds
62.4%
Holding in Top 10
730
Holding in Top 10 Change
-43
Holding in Top 10 Change %
-5.56%
% of All Funds
12.57%
New
115
Increased
1,691
Reduced
1,445
Closed
117
Calls
$3.67B
Puts
$2.74B
Net Calls
+$925M
Net Calls Change
+$91.9M
Name Holding Trade Value Shares
Change
Change in
Stake
HIMC
501
Heritage Investors Management Corp
Maryland
$26.1M -$486K -2,874 -2%
CIP
502
Chartwell Investment Partners
Pennsylvania
$25.9M +$1.73M +10,195 +7%
RG
503
Renaissance Group
Kentucky
$25.8M +$858K +5,072 +3%
BC
504
Blackhill Capital
New Jersey
$25.8M -$67.7K -400 -0.3%
CA
505
CapWealth Advisors
Tennessee
$25.7M -$137K -810 -0.5%
HJGA
506
Hardman Johnston Global Advisors
Connecticut
$25.6M +$226K +1,335 +0.9%
MLICM
507
Metropolitan Life Insurance Company (MetLife)
New York
$25.6M -$332K -1,963 -1%
MAM
508
Meeder Asset Management
Ohio
$25.6M +$931K +5,500 +4%
IAA
509
Independent Advisor Alliance
North Carolina
$25.4M -$1.33M -7,849 -5%
KCM
510
Kanawha Capital Management
Virginia
$25.4M -$231K -1,368 -0.9%
GI
511
GAMCO Investors
Connecticut
$25.3M +$2.98M +17,607 +13%
CAM
512
Cidel Asset Management
Ontario, Canada
$25.3M -$4.47M -26,418 -15%
CCM
513
Coerente Capital Management
Ontario, Canada
$25.3M -$359K -2,119 -1%
FMII
514
Farmers & Merchants Investments Inc
Nebraska
$25.3M +$183K +1,084 +0.7%
CK
515
Cohen Klingenstein
New York
$25.2M
MCM
516
Maple Capital Management
Vermont
$25.2M +$1.08M +6,383 +5%
BDWCC
517
B&D White Capital Company
Texas
$25M +$25.9M +153,295 New
AWS
518
Atria Wealth Solutions
New York
$25M +$13.8M +81,377 +114%
BIP
519
Brandes Investment Partners
California
$24.9M +$1.15M +6,817 +5%
RC
520
Randolph Company
Ohio
$24.9M +$25.7M +152,155 New
WP
521
Woodline Partners
California
$24.8M -$53M -313,066 -67%
HCM
522
Howland Capital Management
Massachusetts
$24.7M +$289K +1,708 +1%
GT
523
Glenview Trust
Kentucky
$24.7M -$271K -1,599 -1%
MHC
524
Meyer Handelman Company
New York
$24.5M -$127K -750 -0.5%
TCOV
525
Trust Company of Vermont
Vermont
$24.2M +$360K +2,126 +1%

JNJ Hedge Fund Activity: Q3 2022 in Review

3,623 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2022, worth a combined $295B — down 8.2% from $321B a quarter earlier.

Sellers outnumbered buyers: 117 funds closed out of JNJ and 115 opened new positions — a net loss of 2 holders — while 1,445 trimmed existing stakes and 1,691 added.

The largest buyer was Amundi, adding an estimated $572M. The largest seller was BlackRock, cutting an estimated $933M.

  • 3,623 institutional investors held Johnson & Johnson (JNJ) as of Q3 2022, down from 3,672 in Q2 2022.
  • Funds reported $295B of Johnson & Johnson stock for Q3 2022, down 8.2% quarter-over-quarter.
  • 115 funds opened new Johnson & Johnson positions in Q3 2022 and 117 closed out, a net change of -2 holders.
  • The largest Johnson & Johnson buyer in Q3 2022 was Amundi, an estimated $572M added.
  • The largest Johnson & Johnson seller in Q3 2022 was BlackRock, an estimated $933M sold.

Based on aggregated 13F filings for Q3 2022.